{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:33:19Z","timestamp":1791293599800,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T00:00:00Z","timestamp":1518998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T00:00:00Z","timestamp":1518998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The aim of this study was to clarify the mechanism of disuse-induced muscle hyperalgesia through the evaluation of the pharmacological behaviour of muscle hyperalgesia profiles in chronic post-cast pain (CPCP) rats with acute and chronic-phase mirror-image muscle hyperalgesia treated with diclofenac (NSAID), pregabalin (an inhibitor of Ca<jats:sup>2+<\/jats:sup> channel \u03b12\u03b4), and duloxetine (SNRI). After 2 weeks of cast immobilization, the peak cross-sectional area and muscle wet weight of the ipsilateral soleus and gastrocnemius muscles decreased more significantly in CPCP rats than in untreated rats. Histological findings revealed disuse-induced muscle atrophy in CPCP rats. The blood biochemical parameters of CPCP rats in acute and chronic phases did not differ significantly from those of untreated rats. The diclofenac and pregabalin-treated groups exhibited no improvement in acute or chronic muscle hyperalgesia. In contrast, the duloxetine-treated group exhibited an improvement in acute muscle hyperalgesia, but showed no apparent effect on chronic muscle hyperalgesia on ipsilateral or contralateral sides. However, the chronic muscle hyperalgesia was reversed by intrathecal administration of DAMGO (a \u03bc-opioid receptor agonist). The results suggest that chronic muscle hyperalgesia in CPCP rats did not result from an inflammatory mechanism, and there is only a low probability that it\u2019s caused by a neuropathic mechanism.<\/jats:p>","DOI":"10.1038\/s41598-018-21429-3","type":"journal-article","created":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T16:42:40Z","timestamp":1518540160000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Therapeutic effects of diclofenac, pregabalin, and duloxetine on disuse-induced chronic musculoskeletal pain in rats"],"prefix":"10.1038","volume":"8","author":[{"given":"Yusuke","family":"Ohmichi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Ohmichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhito","family":"Murai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Yasui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuaki","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidehiro","family":"Oshibuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munekazu","family":"Naito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,19]]},"reference":[{"key":"21429_CR1","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/BF02109988","volume":"5","author":"JW Vlaeyen","year":"1995","unstructured":"Vlaeyen, J. W., Kole-Snijders, A. M., Rotteveel, A. M., Ruesink, R. & Heuts, P. H. The role of fear of movement\/(re)injury in pain disability. J. Occup. Rehabil. 5, 235\u2013252 (1995).","journal-title":"J. Occup. Rehabil."},{"key":"21429_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0304-3959(99)00242-0","volume":"85","author":"JW Vlaeyen","year":"2000","unstructured":"Vlaeyen, J. W. & Linton, S. J. Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art. Pain 85, 317\u2013332 (2000).","journal-title":"Pain"},{"key":"21429_CR3","first-page":"691","volume":"141","author":"WM Bortz 2nd","year":"1984","unstructured":"Bortz, W. M. 2nd. The disuse syndrome. West. J. Med. 141, 691\u2013694 (1984).","journal-title":"West. J. Med."},{"key":"21429_CR4","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1152\/jappl.1982.52.5.1113","volume":"52","author":"FW Booth","year":"1982","unstructured":"Booth, F. W. Effect of limb immobilization on skeletal muscle. J. Appl. Physiol. 52, 1113\u20131118 (1982).","journal-title":"J. Appl. Physiol."},{"key":"21429_CR5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0140-6736(46)90689-7","volume":"2","author":"JZ Young","year":"1946","unstructured":"Young, J. Z. Effects of use and disuse on nerve and muscle. Lancet 2, 109\u2013113 (1946).","journal-title":"Lancet"},{"key":"21429_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S1090-3801(02)00071-X","volume":"7","author":"JA Verbunt","year":"2003","unstructured":"Verbunt, J. A. et al. Disuse and deconditioning in chronic low back pain: concepts and hypotheses on contributing mechanisms. Eur. J. Pain 7, 9\u201321 (2003).","journal-title":"Eur. J. Pain"},{"key":"21429_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0304-3959(00)00332-8","volume":"88","author":"J Maleki","year":"2000","unstructured":"Maleki, J., LeBel, A. A., Bennett, G. J. & Schwartzman, R. J. Patterns of spread in complex regional pain syndrome, type I (reflex sympathetic dystrophy). Pain 88, 259\u2013266 (2000).","journal-title":"Pain"},{"key":"21429_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0304-3959(98)00202-4","volume":"80","author":"O Rommel","year":"1999","unstructured":"Rommel, O. et al. Hemisensory impairment in patients with complex regional pain syndrome. Pain 80, 95\u2013101 (1999).","journal-title":"Pain"},{"key":"21429_CR9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0304-3959(01)00332-3","volume":"93","author":"O Rommel","year":"2001","unstructured":"Rommel, O., Malin, J. P., Zenz, M. & Janig, W. Quantitative sensory testing, neurophysiological and psychological examination in patients with complex regional pain syndrome and hemisensory deficits. Pain 93, 279\u2013293 (2001).","journal-title":"Pain"},{"key":"21429_CR10","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0304-3959(98)00246-2","volume":"80","author":"G Allen","year":"1999","unstructured":"Allen, G., Galer, B. S. & Schwartz, L. Epidemiology of complex regional pain syndrome: a retrospective chart review of 134 patients. Pain 80, 539\u2013544 (1999).","journal-title":"Pain"},{"key":"21429_CR11","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/0885-3924(95)00061-3","volume":"10","author":"BS Galer","year":"1995","unstructured":"Galer, B. S., Butler, S. & Jensen, M. P. Case reports and hypothesis: a neglect-like syndrome may be responsible for the motor disturbance in reflex sympathetic dystrophy (Complex Regional Pain Syndrome-1). J. Pain Symptom Manage. 10, 385\u2013391 (1995).","journal-title":"J. Pain Symptom Manage."},{"key":"21429_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1212\/WNL.40.1.57","volume":"40","author":"RJ Schwartzman","year":"1990","unstructured":"Schwartzman, R. J. & Kerrigan, J. The movement disorder of reflex sympathetic dystrophy. Neurology 40, 57\u201361 (1990).","journal-title":"Neurology"},{"key":"21429_CR13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/ALN.0b013e31817f4c9d","volume":"109","author":"AJ Terkelsen","year":"2008","unstructured":"Terkelsen, A. J., Bach, F. W. & Jensen, T. S. Experimental forearm immobilization in humans induces cold and mechanical hyperalgesia. Anesthesiology 109, 297\u2013307 (2008).","journal-title":"Anesthesiology"},{"key":"21429_CR14","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/j.1532-2149.2011.00026.x","volume":"16","author":"Y Ohmichi","year":"2012","unstructured":"Ohmichi, Y. et al. Two-week cast immobilization induced chronic widespread hyperalgesia in rats. Eur. J. Pain 16, 338\u2013348 (2012).","journal-title":"Eur. J. Pain"},{"key":"21429_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-10-6","volume":"10","author":"M Ohmichi","year":"2014","unstructured":"Ohmichi, M. et al. Activated spinal astrocytes are involved in the maintenance of chronic widespread mechanical hyperalgesia after cast immobilization. Mol. Pain 10, 6 (2014).","journal-title":"Mol. Pain"},{"key":"21429_CR16","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/pme.12033","volume":"14","author":"RN Harden","year":"2013","unstructured":"Harden, R. N. et al. Complex regional pain syndrome: practical diagnostic and treatment guidelines, 4th edition. Pain Med. 14, 180\u2013229 (2013).","journal-title":"Pain Med."},{"key":"21429_CR17","doi-asserted-by":"publisher","first-page":"e834","DOI":"10.3928\/01477447-20120525-21","volume":"35","author":"SK Lee","year":"2012","unstructured":"Lee, S. K., Yang, D. S., Lee, J. W. & Choy, W. S. Four treatment strategies for complex regional pain syndrome type 1. Orthopedics 35, e834\u2013842 (2012).","journal-title":"Orthopedics"},{"key":"21429_CR18","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S1474-4422(03)00557-X","volume":"2","author":"W J\u00e4nig","year":"2003","unstructured":"J\u00e4nig, W. & Baron, R. Complex regional pain syndrome: mystery explained? Lancet Neurol. 2, 687\u2013697 (2003).","journal-title":"Lancet Neurol."},{"key":"21429_CR19","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S1474-4422(11)70106-5","volume":"10","author":"J Marinus","year":"2011","unstructured":"Marinus, J. et al. Clinical features and pathophysiology of complex regional pain syndrome. Lancet Neurol. 10, 637\u2013648 (2011).","journal-title":"Lancet Neurol."},{"key":"21429_CR20","doi-asserted-by":"publisher","unstructured":"Lunn, M. P., Hughes, R. A. & Wiffen, P. J. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst. Rev., CD007115, https:\/\/doi.org\/10.1002\/14651858.CD007115.pub3 (2014).","DOI":"10.1002\/14651858.CD007115.pub3"},{"key":"21429_CR21","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","volume":"132","author":"RH Dworkin","year":"2007","unstructured":"Dworkin, R. H. et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 132, 237\u2013251 (2007).","journal-title":"Pain"},{"key":"21429_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-4-13","volume":"4","author":"AC van de Vusse","year":"2004","unstructured":"van de Vusse, A. C., Stomp-van den Berg, S. G., Kessels, A. H. & Weber, W. E. Randomised controlled trial of gabapentin in Complex Regional Pain Syndrome type 1 [ISRCTN84121379]. BMC Neurol. 4, 13 (2004).","journal-title":"BMC Neurol."},{"key":"21429_CR23","unstructured":"Merskey, H. & Bogduk, N. Classification of Chronic Pain. 2nd edn, (IASP Press, 1994)."},{"key":"21429_CR24","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.amjmed.2009.09.006","volume":"122","author":"DJ Clauw","year":"2009","unstructured":"Clauw, D. J. Fibromyalgia: an overview. Am. J. Med. 122, S3\u2013S13 (2009).","journal-title":"Am. J. Med."},{"key":"21429_CR25","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/S0140-6736(11)60610-7","volume":"379","author":"F Balague","year":"2012","unstructured":"Balague, F., Mannion, A. F., Pellise, F. & Cedraschi, C. Non-specific low back pain. Lancet 379, 482\u2013491 (2012).","journal-title":"Lancet"},{"key":"21429_CR26","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1056\/NEJM200102013440508","volume":"344","author":"RA Deyo","year":"2001","unstructured":"Deyo, R. A. & Weinstein, J. N. Low back pain. N. Engl. J. Med. 344, 363\u2013370 (2001).","journal-title":"N. Engl. J. Med."},{"key":"21429_CR27","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1111\/pme.12456","volume":"15","author":"S Rej","year":"2014","unstructured":"Rej, S., Dew, M. A. & Karp, J. F. Treating concurrent chronic low back pain and depression with low-dose venlafaxine: an initial identification of \u201ceasy-to-use\u201d clinical predictors of early response. Pain Med. 15, 1154\u20131162 (2014).","journal-title":"Pain Med."},{"key":"21429_CR28","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/ar3306","volume":"13","author":"YC Lee","year":"2011","unstructured":"Lee, Y. C., Nassikas, N. J. & Clauw, D. J. The role of the central nervous system in the generation and maintenance of chronic pain in rheumatoid arthritis, osteoarthritis and fibromyalgia. Arthritis Res. Ther. 13, 211 (2011).","journal-title":"Arthritis Res. Ther."},{"key":"21429_CR29","doi-asserted-by":"publisher","unstructured":"Derry, S., Phillips, T., Moore, R. A. & Wiffen, P. J. Milnacipran for neuropathic pain in adults. Cochrane Database Syst. Rev., CD011789, https:\/\/doi.org\/10.1002\/14651858.CD011789 (2015).","DOI":"10.1002\/14651858.CD011789"},{"issue":"Suppl 1","key":"21429_CR30","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1097\/01.j.pain.0000460344.54470.20","volume":"156","author":"F Birklein","year":"2015","unstructured":"Birklein, F. & Schlereth, T. Complex regional pain syndrome-significant progress in understanding. Pain 156(Suppl 1), S94\u2013103 (2015).","journal-title":"Pain"},{"key":"21429_CR31","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1016\/j.pain.2013.08.004","volume":"154","author":"DE van Rooijen","year":"2013","unstructured":"van Rooijen, D. E., Marinus, J. & van Hilten, J. J. Muscle hyperalgesia is widespread in patients with complex regional pain syndrome. Pain 154, 2745\u20132749 (2013).","journal-title":"Pain"},{"key":"21429_CR32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.pain.2003.12.010","volume":"108","author":"TZ Guo","year":"2004","unstructured":"Guo, T. Z., Offley, S. C., Boyd, E. A., Jacobs, C. R. & Kingery, W. S. Substance P signaling contributes to the vascular and nociceptive abnormalities observed in a tibial fracture rat model of complex regional pain syndrome type I. Pain 108, 95\u2013107 (2004).","journal-title":"Pain"},{"key":"21429_CR33","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.jpain.2014.07.004","volume":"15","author":"TZ Guo","year":"2014","unstructured":"Guo, T. Z. et al. Immobilization contributes to exaggerated neuropeptide signaling, inflammatory changes, and nociceptive sensitization after fracture in rats. J. Pain 15, 1033\u20131045 (2014).","journal-title":"J. Pain"},{"key":"21429_CR34","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.pain.2005.08.013","volume":"118","author":"NB Finnerup","year":"2005","unstructured":"Finnerup, N. B., Otto, M., McQuay, H. J., Jensen, T. S. & Sindrup, S. H. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 118, 289\u2013305 (2005).","journal-title":"Pain"},{"key":"21429_CR35","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.pain.2005.02.032","volume":"115","author":"R Freynhagen","year":"2005","unstructured":"Freynhagen, R., Strojek, K., Griesing, T., Whalen, E. & Balkenohl, M. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain 115, 254\u2013263 (2005).","journal-title":"Pain"},{"key":"21429_CR36","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.jpain.2010.02.024","volume":"11","author":"M Tuchman","year":"2010","unstructured":"Tuchman, M., Barrett, J. A., Donevan, S., Hedberg, T. G. & Taylor, C. P. Central sensitization and Ca(V)alpha(2)delta ligands in chronic pain syndromes: pathologic processes and pharmacologic effect. J. Pain 11, 1241\u20131249 (2010).","journal-title":"J. Pain"},{"key":"21429_CR37","doi-asserted-by":"publisher","first-page":"4076","DOI":"10.1523\/JNEUROSCI.0356-09.2009","volume":"29","author":"CS Bauer","year":"2009","unstructured":"Bauer, C. S. et al. The increased trafficking of the calcium channel subunit alpha2delta-1 to presynaptic terminals in neuropathic pain is inhibited by the alpha2delta ligand pregabalin. J. Neurosci. 29, 4076\u20134088 (2009).","journal-title":"J. Neurosci."},{"key":"21429_CR38","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0304-3959(99)00111-6","volume":"83","author":"MJ Field","year":"1999","unstructured":"Field, M. J., Bramwell, S., Hughes, J. & Singh, L. Detection of static and dynamic components of mechanical allodynia in rat models of neuropathic pain: are they signalled by distinct primary sensory neurones? Pain 83, 303\u2013311 (1999).","journal-title":"Pain"},{"key":"21429_CR39","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.neuropharm.2005.08.004","volume":"49","author":"W Gaida","year":"2005","unstructured":"Gaida, W., Klinder, K., Arndt, K. & Weiser, T. Ambroxol, a Nav1.8-preferring Na(+) channel blocker, effectively suppresses pain symptoms in animal models of chronic, neuropathic and inflammatory pain. Neuropharmacology 49, 1220\u20131227 (2005).","journal-title":"Neuropharmacology"},{"key":"21429_CR40","doi-asserted-by":"publisher","first-page":"17537","DOI":"10.1073\/pnas.0409066103","volume":"103","author":"MJ Field","year":"2006","unstructured":"Field, M. J. et al. Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. Proc. Natl. Acad. Sci. USA 103, 17537\u201317542 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"21429_CR41","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/j.1742-1241.2007.01433.x","volume":"61","author":"KB Thor","year":"2007","unstructured":"Thor, K. B., Kirby, M. & Viktrup, L. Serotonin and noradrenaline involvement in urinary incontinence, depression and pain: scientific basis for overlapping clinical efficacy from a single drug, duloxetine. Int. J. Clin. Pract. 61, 1349\u20131355 (2007).","journal-title":"Int. J. Clin. Pract."},{"key":"21429_CR42","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.pain.2004.09.015","volume":"112","author":"H Imbe","year":"2004","unstructured":"Imbe, H., Murakami, S., Okamoto, K., Iwai-Liao, Y. & Senba, E. The effects of acute and chronic restraint stress on activation of ERK in the rostral ventromedial medulla and locus coeruleus. Pain 112, 361\u2013371 (2004).","journal-title":"Pain"},{"key":"21429_CR43","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0301-0082(02)00009-6","volume":"66","author":"MJ Millan","year":"2002","unstructured":"Millan, M. J. Descending control of pain. Prog. Neurobiol. 66, 355\u2013474 (2002).","journal-title":"Prog. Neurobiol."},{"key":"21429_CR44","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1002\/glia.20871","volume":"57","author":"K Inoue","year":"2009","unstructured":"Inoue, K. & Tsuda, M. Microglia and neuropathic pain. Glia 57, 1469\u20131479 (2009).","journal-title":"Glia"},{"key":"21429_CR45","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1002\/glia.22687","volume":"62","author":"M Yasui","year":"2014","unstructured":"Yasui, M. et al. A chronic fatigue syndrome model demonstrates mechanical allodynia and muscular hyperalgesia via spinal microglial activation. Glia 62, 1407\u20131417 (2014).","journal-title":"Glia"},{"key":"21429_CR46","doi-asserted-by":"publisher","first-page":"e0165189","DOI":"10.1371\/journal.pone.0165189","volume":"11","author":"T Yamashita","year":"2016","unstructured":"Yamashita, T. et al. Duloxetine inhibits microglial P2X4 receptor function and alleviates neuropathic pain after peripheral nerve injury. PLoS One 11, e0165189 (2016).","journal-title":"PLoS One"},{"key":"21429_CR47","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/nature01786","volume":"424","author":"M Tsuda","year":"2003","unstructured":"Tsuda, M. et al. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424, 778\u2013783 (2003).","journal-title":"Nature"},{"key":"21429_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-5-28","volume":"5","author":"M Tsuda","year":"2009","unstructured":"Tsuda, M. et al. Behavioral phenotypes of mice lacking purinergic P2X4 receptors in acute and chronic pain assays. Mol. Pain 5, 28 (2009).","journal-title":"Mol. Pain"},{"key":"21429_CR49","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.pain.2005.05.035","volume":"117","author":"T Kohno","year":"2005","unstructured":"Kohno, T. et al. Peripheral axonal injury results in reduced mu opioid receptor pre- and post-synaptic action in the spinal cord. Pain 117, 77\u201387 (2005).","journal-title":"Pain"},{"key":"21429_CR50","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.neulet.2012.11.009","volume":"534","author":"A Morimoto","year":"2013","unstructured":"Morimoto, A. et al. Treadmill running and static stretching improve long-lasting hyperalgesia, joint limitation, and muscle atrophy induced by cast immobilization in rats. Neurosci. Lett. 534, 295\u2013300 (2013).","journal-title":"Neurosci. Lett."},{"key":"21429_CR51","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.pain.2004.08.001","volume":"112","author":"TJ Coderre","year":"2004","unstructured":"Coderre, T. J., Xanthos, D. N., Francis, L. & Bennett, G. J. Chronic post-ischemia pain (CPIP): a novel animal model of complex regional pain syndrome-type I (CRPS-I; reflex sympathetic dystrophy) produced by prolonged hindpaw ischemia and reperfusion in the rat. Pain 112, 94\u2013105 (2004).","journal-title":"Pain"},{"key":"21429_CR52","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.neuroscience.2008.02.031","volume":"153","author":"T Kiso","year":"2008","unstructured":"Kiso, T. et al. Pharmacological characterization and gene expression profiling of an L5\/L6 spinal nerve ligation model for neuropathic pain in mice. Neuroscience 153, 492\u2013500 (2008).","journal-title":"Neuroscience"},{"key":"21429_CR53","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.neuropharm.2013.10.030","volume":"79","author":"N Murai","year":"2014","unstructured":"Murai, N. et al. AS1069562, the (+)-isomer of indeloxazine, but not duloxetine has a curative-like analgesic effect in a rat model of streptozotocin-induced diabetic neuropathy. Neuropharmacology 79, 10\u201316 (2014).","journal-title":"Neuropharmacology"},{"key":"21429_CR54","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1124\/jpet.110.167924","volume":"334","author":"E Yoshimi","year":"2010","unstructured":"Yoshimi, E. et al. Antinociceptive effects of AS1892802, a novel Rho kinase inhibitor, in rat models of inflammatory and noninflammatory arthritis. J. Pharmacol. Exp. Ther. 334, 955\u2013963 (2010).","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21429-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21429-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21429-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T02:34:18Z","timestamp":1671590058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21429-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,19]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["21429"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-21429-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,19]]},"assertion":[{"value":"14 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"3311"}}